Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cigna Corp (CI) vs Mondaycom Ltd (MNDY) Price & Performance

Cigna CorpTrade
Mondaycom LtdTrade

Price performance (Past 24H)

Key statistics

Cigna Corp vs Mondaycom Ltd — how do they compare? Cigna Corp trades at $300.3 (market cap $80.25B), while Mondaycom Ltd trades at $82.82 (market cap $3.51B). The key difference: Cigna Corp is far larger — about 22.9× Mondaycom Ltd's market cap, and Cigna Corp pays a 2.06% dividend while Mondaycom Ltd pays none. Which is the better fit depends on your goals.

CIMNDY
Market Cap
$80.25B$3.51B
Sector
HealthTechnology
52-Week High
$311.00$292.24
52-Week Low
$244.41$58.81
Enterprise Value
$103.35B$2.47B
Dividend Yield
2.06%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cigna Corp

Cigna (CI) trades at $304.50, up 3.76% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $7.79 exceeding the $7.60 estimate. Valuation metrics appear attractive with a P/E of 12.91 and P/S of 0.29. Recent news highlights strategic AI investments in pharmacy services and positive sector sentiment.

The investment case centers on undervaluation, earnings momentum, and dividend yield, though risks include regulatory challenges and moderating cash flow. With a consensus price target of $339.82 implying 11.6% upside, Wall Street maintains a bullish stance, but investors should weigh execution risks against growth initiatives.

Mondaycom Ltd

Monday.com (MNDY) trades at $86.84, up 5.3% in the past 24 hours, with a bullish technical outlook and strong analyst support. The stock has consistently beaten earnings expectations, with Q1 2026 EPS of $1.15 surpassing the $0.96 estimate. Revenue grew to $1.23 billion in 2025, though net income remained flat at $119 million year-over-year. Recent news highlights investor attention amid a 51% decline in the first half of 2026, with some viewing the dip as a buying opportunity due to solid fundamentals.

The outlook for MNDY is positive, driven by robust revenue growth, high gross margins of 89.05%, and a unanimous analyst buy consensus with a $115.50 price target. Key risks include elevated valuation multiples, competitive pressures in the SaaS space, and volatility from AI disruption concerns. Investors should weigh the company's execution against its premium pricing.

Returns comparison

Trailing returns across standard periods

About Cigna Corp

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.

Read more on CI

About Mondaycom Ltd

Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.

Read more on MNDY